Bioseeker, Feb 2011
the last years amount to another 61 (59) drugs. BrainCancerDrugPipelineUpdate lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 131 (114) different
BioPharm Reports (VennBio Ltd.), Jan 2011, Pages: 124
, based on new and established classes. This 2011 report gives a comprehensive update on current therapeutic and diagnostic development in this field, on the drug development pipeline and the most promising
Espicom Business Intelligence Ltd, May 2011
savings.
CANCER ANALYSIS PROVIDES:
- Company Performance, Products and Research Pipelines:
Regularly updated and detailed analysis of over 120 leading companies' strategy, research, products
Global Markets Direct, Jan 2011, Pages: 149
BrainCancer - Pipeline Review, Q1 2011
Summary
Global Markets Direct’s, 'BrainCancer - Pipeline Review, Q1 2011', provides an overview of the BrainCancer therapeutic pipeline. This report
Global Markets Direct, Jan 2012, Pages: 183
BrainCancer – Pipeline Review, H1 2012
Summary
Global Markets Direct’s, 'BrainCancer - Pipeline Review, H1 2012', provides an overview of the BrainCancer therapeutic pipeline. This report
Bioseeker, Dec 2007, Pages: 430
by Molecular Function Classes of Targets 3(3)
Figure 4: Pipeline Maturation of Carboxypeptidase Activity Targets
Figure 5: Number of Antibody Drugs per Cancer Indication and Carboxypeptidase Activity Target
Global Markets Direct, Oct 2011, Pages: 71
Patients In Phase II BrainCancer Trial
Aug 28, 2006: Northwest Biotherapeutics UpdatesBrainCancer Clinical Data For DCVax-Brain
May 25, 2011: Northwest Biotherapeutics Further Expands Ongoing Brain
Jain PharmaBiotech, Feb 2012, Pages: 659
therapy
Brain tumors in cats and dogs
Breast cancer in dogs
Canine hemangiosarcoma
Canine melanoma
Canine soft tissue sarcoma
Melanoma in horses
4. Gene Therapy of Genetic Disorders
Introduction
Global Markets Direct, Dec 2010, Pages: 54
-Up Data Of DCVax-Brain Immune Therapy In BrainCancer Patients
Oct 21, 2009: Long-Term Data Updates Show Further Extensions Of Survival And Delays In Recurrence In BrainCancer Patients Who Received
Global Markets Direct, July 2011, Pages: 327
BrainCancer Therapeutics – Drug Profile Updates
Discontinued Products
List of Figures
Number of Products under Development for BrainCancer, Q3 2011
Products under Development for Brain
Global Markets Direct, Oct 2011, Pages: 118
At The 2007 American Society Of Clinical Oncology Annual Meeting
Apr 23, 2007: Pharmacyclics Announces FDA Filing Of New Drug Application For Xcytrin Injection To Treat Lung CancerBrain Metastases
Dec 22
Global Markets Direct, Nov 2011, Pages: 126
” provides data on the Peregrine Pharmaceuticals, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features
Global Markets Direct, Oct 2011, Pages: 39
Drug Activates Guardian Angel p53 In Fight Against leukemia
Mar 02, 2011: Cellceutix's CancerDrug Kevetrin Shows No Genotoxicity In Study
Aug 01, 2011: Cellceutix Provides Update On Clinical
Global Markets Direct, Dec 2010, Pages: 32
’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data
Global Markets Direct, Nov 2011, Pages: 79
Orphan Drug Designation for Gliadel Wafer(Polifeprosan 20 With Carmustine Implant) for Treatment of BrainCancer
Feb 27, 2003: Approves Guilford's Gliadel As First-line Therapy For Glioma.
Feb 26
Global Markets Direct, Nov 2011, Pages: 31
data on the Stemline Therapeutics, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued
GlobalData, Nov 2010, Pages: 49
” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant
Global Markets Direct, Nov 2010, Pages: 49
” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant
Global Markets Direct, Nov 2011, Pages: 76
Vaccine In BrainCancer
Dec 09, 2003: Antigenics Reports Update On Cancer Vaccine Clinical Trials At American Society of Hematology (ASH) Meeting
Nov 09, 1999: Aronex Pharmaceuticals Receives Orphan
